Abstract
One approach to drug design involves determination of the structure of binding sites on target proteins to provide templates for ligand construction. Alternatively, random combinations of chemical groups can be used to generate diverse molecules for screening in the search for effective compounds1. Here we report a strategy for developing potent ligands for proteins with multiple binding sites, which combines elements of both approaches: ‘polymer-linked ligand dimers’, in which two ligands are joined by a polymer chain of variable length. We find that polymer-linked ligand dimers containing two cyclic GMP moieties are up to a thousand times more potent than cyclic GMP in activating cyclic-nucleotide-gated channels and cGMP-dependent protein kinase. Each target protein responds optimally to a polymer-linked ligand dimer with a different average polymer length, even though their cyclic-nucleotide-binding sites are conserved. The tuning of polymer-linked ligand dimers indicates that each protein has a unique spacing of binding sites and provides an estimate of the distance between these sites. As optimal ligands are selected empirically, the polymer-linked ligand dimer strategy enables potent and selective agents to be identified without requiring previous structural information about the target proteins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gallop, M. A., Barrett, R. W., Dower, W. J., Fodor, S. P. & Gordon, E. M. Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries J. Med. Chem. 37, 1233–1251 (1994).
Finn, J. T., Grunwald, M. E. & Yau, K.-W. Cyclic nucleotide-gated ion channels: an extended family with diverse functions Annu. Rev. Physiol. 58, 395–426 (1996).
Zagotta, W. N. & Siegelbaum, S. A. Structure and function of cyclic nucleotide-gated channels Annu. Rev. Neurosci. 19, 235–263 (1996).
Francis, S. H. & Corbin, J. D. Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase Adv. Pharm. 26, 115–170 (1994).
Taylor, S. S., Buechler, J. A. & Yonemoto, W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes Annu. Rev. Biochem. 59, 971–1005 (1990).
Liu, D. T., Tibbs, G. R. & Siegelbaum, S. A. Subunit stoichiometry of cyclic nucleotide-gated channels and effects of subunit order on channel function Neuron 16, 983–990 (1996).
Shabb, J. B. & Corbin, J. D. Cyclic nucleotide-binding domains in proteins having diverse functions J. Biol. Chem. 267, 5723–5726 (1992).
Botelho, L. H., Rothermael, J. D., Coombs, R. V. & Jastorff, B. cAMP analog antagonists of cAMP action Meth. Enzymol. 159, 159–172 (1988).
Butt, E., Van Bemmelen, M., Fischer, L., Walter, U. & Jastorff, B. Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates FEBS Lett. 263, 47–50 (1990).
Butt, E., Eigenthaler, M. & Genieser, H. G. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor Eur. J. Pharmacol. 269, 265–268 (1994).
Kramer, R. H. & Tibbs, G. R. Antagonists of cyclic nucleotide-gated channels and molecular mapping of their site of action J. Neurosci. 16, 1285–1293 (1996).
Wei, J.-Y., Cohen, E. D., Yan, Y.-Y., Genieser, H.-G. & Barnstable, C. J. Identification of competitive antagonists of the rod photoreceptor cGMP-gated cation channel: beta-phenyl-1,N2-etheno-substituted cGMP analogues as probes of the cGMP-binding site Biochemistry 35, 16815–16823 (1996).
Brown, R. L., Bert, R. J., Evans, F. E. & Karpen, J. W. Activation of retinal rod cGMP-gated channels: what makes for an effective 8-substituted derivative of cGMP? Biochemistry 32, 10089–10095 (1993).
Zimmerman, A. L., Yamanaka, G., Eckstein, F., Baylor, D. A. & Stryer, L. Interaction of hydrolysis-resistant analogs of cyclic GMP with the phosphodiesterase and light-sensitive channel of retinal rod outer segments Proc. Natl Acad. Sci. USA 82, 8813–8817 (1985).
Cartetta, A., Cavaggioni, A. & Sorbi, R. T. Binding stoichiometry of a fluorescent cGMP analogue to membranes of retinal rod outer segments Eur. J. Biochem. 153, 49–53 (1985).
Koch, K.-W. & Kaupp, U. B. Cyclic GMP directly regulates a cation conductance in membranes of bovine rods by a cooperative mechanism J. Biol. Chem. 260, 6788–6800 (1985).
Tanaka, J. C., Eccleston, J. F. & Furman, R. E. Photoreceptor channel activation by nucleotide derivatives Biochemistry 28, 2776–2784 (1989).
Knoll, D. & Hermans, J. Polymer–protein interactions. Comparison of experiment and excluded volume theory J. Biol. Chem. 258, 5710–5715 (1983).
Florey, P. J. Principles of Polymer Chemistry (Cornell Univ. Press, Ithaca, New York, (1953)).
Dhallan, R. S., Yau, K.-W., Schrader, K. A. & Reed, R. R. Primary structure and functional expression of a cyclic-nucleotide-activated channel from olfactory neurons. Nature 347, 184–187 (1990).
Kaupp, U. B. et al . Primary structure and functional expression from complementary DNA of the rod photoreceptor cyclic GMP-gated channel. Nature 342, 762–766 (1989).
Goulding, E. H., Tibbs, G. R., Liu, D. & Siegelbaum, S. A. Role of H5 domain in determining pore diameter and ion permeation through cyclic nucleotide-gated channels. Nature 364, 61–64 (1993).
Su, Y. et al . Regulatory subunit of protein kinase A: structure of deletion mutant with cAMP binding domains Science 269, 807–813 (1995).
Chen, T.-Y. et al . Anew subunit of the cyclic nucleotide-gated cation channel in retinal rods. Nature 362, 764–767 (1993).
Liman, E. R. & Buck, L. B. Asecond subunit of the olfactory cyclic nucleotide-gated channel confers high sensitivity to cAMP Neuron 13, 611–621 (1994).
Bradley, J., Li, J., Davidson, N., Lester, H. A. & Zinn, K. Heteromeric olfactory cyclic nucleotide-gated channels: a subunit that confers increased sensitivity to cAMP Proc. Natl Acad. Sci. USA 91, 8890–8894 (1994).
Körschen, H. G. et al . A240 kDa protein represents the complete beta subunit of the cyclic nucleotide-gated channel from rod photoreceptor Neuron 15, 627–636 (1995).
Sekhar, K. R. et al . Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase Mol. Pharmacol. 42, 103–108 (1992).
Acknowledgements
We thank P. Fennessey and L. Miller for mass spectrometry, E. Nelson for technical help, and C. Barski for assistance with artwork. This work was supported by grants from the NIH (to R.H.K. and J.W.K.) and the American Heart Association.
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Rights and permissions
About this article
Cite this article
Kramer, R., Karpen, J. Spanning binding sites on allosteric proteins with polymer-linked ligand dimers. Nature 395, 710–713 (1998). https://doi.org/10.1038/27227
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/27227
This article is cited by
-
Structure-specific amyloid precipitation in biofluids
Nature Chemistry (2022)
-
Quantifying and controlling bond multivalency for advanced nanoparticle targeting to cells
Nano Convergence (2021)
-
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin
Nature Biomedical Engineering (2021)
-
Development of Targeting Ligands for HER2 Receptor: Simplified Receptor Model Employed for Selecting Highly Specific Molecules
International Journal of Peptide Research and Therapeutics (2016)
-
Conotoxin αD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors
Scientific Reports (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.